Kardion Inc.

About Kardion

Kardion is a medical technology company founded in 2018, headquartered in Pleasanton, California, with a location in Stuttgart. The company develops mechanical circulatory support systems (MCS) for cardiovascular patients. The central product is the KARDION CORY P4 system, a percutaneous MCS system for hemodynamic support during high-risk PCI procedures, which is currently being evaluated for safety and efficacy in a pivotal study (NCT06445608) involving approximately 310 patients. According to the company, the team combines deep expertise in engineering and medical technology and is guided by the principles of Rigor, Honesty and Evidence. Kardion is privately funded (investor: Revival Healthcare Capital) and, according to PitchBook, holds 234 granted and 156 pending patents, among other things on rotor bearings, impeller housings and radiopaque markers for heart support systems.

Site

Pleasanton, CA

Processes

Mechanical Circulatory Support (CORY P4 System), Clinical Trial Management (pivotal trial NCT06445608)

Materials

Mechanical Circulatory Support (CORY P4)

Founded

2018

Employees

51-200 (LinkedIn),

Industries

Medical Technology, Cardiovascular Technologies

1. 01

   Research and Development

2. 02

   Patent Protection and Design

3. 03

   Clinical Trial Management

4. 04

   Regulatory Affairs and Quality Assurance

Development Focus Areas

Locations

Inside the production

History

1. 2018

   Company founding

2. 2024

   Start of the pivotal study of the KARDION CORY P4 MCS system (NCT06445608)